Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Sponsor: Osprey Medical, Inc
Terminated
Study closed by sponsor prior to completing enrollment goal.
Other terminated trials from Osprey Medical, Inc
More terminations from Osprey Medical, Inc
A NA clinical study on Radiographic Contrast Agent Nephropathy, this trial is terminated or withdrawn. The trial is conducted by Osprey Medical, Inc and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Osprey Medical, Inc
For direct contact, visit the study record on ClinicalTrials.gov .